Retevmo improved event-free survival in stage 2 to 3A RET fusion-positive non-small cell lung cancer after curative therapy, per phase 3 data. Retevmo (selpercatinib) significantly improved event-free ...
SCLC diagnosis involves imaging, biopsies, and lab tests to assess tumor spread and guide treatment decisions. Treatment options vary by stage, with surgery, chemotherapy, radiation, and immunotherapy ...
April 3 (Reuters) - Doctors should not automatically rule out surgery for octogenarians with early-stage lung cancer, according to a new study that challenges longstanding assumptions about age and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results